Publications by authors named "I Dumas"
Thyroid cancer (TC), due to its heterogeneous nature, remains a clinical challenge. Many factors can initiate the carcinogenesis process of various types of TC, which complicates diagnosis and treatment. The presented review gathers current information on specific types of TC, taking into account the effects of the COVID-19 pandemic.
View Article and Find Full Text PDFArticle Synopsis
- This study looks at which cervical cancer patients might do better with a special kind of treatment called pulsed-dose-rate (PDR) brachytherapy compared to high-dose-rate (HDR).
- They studied 50 patients to compare the two treatments and used special models to see how effective each treatment would be.
- The results showed that only a few patients really benefited from PDR, with specific measurements helping doctors figure out who would get the most help from it.
The number of patients with unilateral above-knee amputation (AKA) due to non-vascular causes has remained stable over the years, at 0.92 per 1000 people per year. Post-AKA individuals are at risk of experiencing a higher incidence of chronic pain.
View Article and Find Full Text PDFArticle Synopsis
- Stage III NSCLC is a diverse group of patients with various treatment options, including surgery, radiotherapy, and chemotherapy, with insights from the PACIFIC trial influencing current strategies.
- A study at the University Hospital Grenoble Alpes from 2010 to 2017 analyzed the treatment outcomes of 476 Stage III NSCLC patients, finding that only 62% of those scheduled for surgery actually underwent the procedure.
- Patients who had neoadjuvant chemotherapy followed by surgery had a median overall survival of 53.2 months, compared to 23.9 months for those treated with chemoradiotherapy; however, switching from surgery to chemoradiotherapy was linked to decreased survival, highlighting the importance of a multidisciplinary approach in
Background: At least half of patients with lung cancer have comorbidities, which can affect treatment decisions and survival. Associated with comorbidity, polypharmacy can also have consequences on patient care. This study will evaluate both polypharmacy and comorbidities in a cohort of hospitalized patients on the administration of chemotherapy and survival.
View Article and Find Full Text PDF